StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.29−0.14 (-0.88%)

Close on Nov 17, 2026Market cap $82.32MP/E 3.4Yield –

Rallybio total assets

Total assets on the balance sheet at the end of each period.

Rallybio's total assets was $95.58M at Sep 30, 2026. For fiscal 2025 it was $62.26M, down 8.6% from the year before. The highest annual figure on record is $182.19M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$62.26M-8.6%
FY2024Dec 31, 2024$68.11M-41.1%
FY2023Dec 31, 2023$115.62M-35.9%
FY2022Dec 31, 2022$180.44M-1.0%
FY2021Dec 31, 2021$182.19M+28.4%
FY2020Dec 31, 2020$141.86M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$95.58M+41.3%
Q2 FY2026Jun 30, 2026$98.06M+92.3%
Q1 FY2026Mar 31, 2026$54.47M-6.1%
Q4 FY2025Dec 31, 2025$62.26M-8.6%
Q3 FY2025Sep 30, 2025$67.66M-14.4%
Q2 FY2025Jun 30, 2025$51.00M-44.8%
Q1 FY2025Mar 31, 2025$57.98M-41.6%
Q4 FY2024Dec 31, 2024$68.11M-41.1%
Q3 FY2024Sep 30, 2024$79.01M-40.7%
Q2 FY2024Jun 30, 2024$92.43M-37.4%
Q1 FY2024Mar 31, 2024$99.36M-38.8%
Q4 FY2023Dec 31, 2023$115.62M-35.9%
Q3 FY2023Sep 30, 2023$133.19M-7.3%
Q2 FY2023Jun 30, 2023$147.58M-5.2%
Q1 FY2023Mar 31, 2023$162.32M-4.2%
Q4 FY2022Dec 31, 2022$180.44M-1.0%
Q3 FY2022Sep 30, 2022$143.67M-25.9%
Q2 FY2022Jun 30, 2022$155.61M+29.6%
Q1 FY2022Mar 31, 2022$169.35M+19.4%
Q4 FY2021Dec 31, 2021$182.19M–
Q3 FY2021Sep 30, 2021$193.87M–
Q2 FY2021Jun 30, 2021$120.10M–
Q4 FY2020Dec 31, 2020$141.86M–

More Rallybio figures

See a number that looks wrong?